Abstract
Objectives
Late-life disability in Activities of Daily Living (ADL) is theorized to be driven by underlying cognitive and/or physical impairment, interacting with psychological and environmental factors. While we expect that cognitive deficits would explain associations between ADL disability and dementia risk, the current study examined ADL as a predictor of future dementia after controlling for global cognitive status.
Methods
The population-based Cache County Memory Study (CCMS; N=3547) assessed individuals in four triennial waves (average age 74.9, years of education 13.36; 57.9% were women). Cox proportional hazards regression models assessed whether baseline ADL disability (presence of 2+ Instrumental ADL and/or 1+ Personal ADL) predicted incident dementia after controlling for APOE status, gender, age, baseline cognitive ability (Modified Mini-mental State Exam, 3MS-R; adjusted for education level), and baseline depressive symptoms (Diagnostic Interview Schedule).
Results
Over the course of study, 571 cases of incident dementia were identified through in-depth cognitive assessment, ending in expert consensus diagnosis. Results from Cox models suggest that ADL disability is a statistically significant predictor of incident dementia (adjusted Hazard Ratio=1.83, p<.001), even after controlling for covariate.
Conclusions
Findings suggest that ADL disability offers unique contributions in risk for incident dementia, even after controlling for global cognitive status. We discuss how physical impairment and executive function may play important roles in this relationship, and how ADL is useful, not just a diagnostic tool at, or after dementia onset, but as a risk factor for future dementia, even in individuals not impaired on global cognitive tests.
Keywords: Activities of Daily Living, Dementia risk, Disability
INTRODUCTION
Dementia is a significant public health challenge, and risk factors have been extensively examined. Multiple review articles (Chen et al., 2009; Daviglus et al., 2010; McCullagh et al., 2001) suggest that genetic factors (e.g. the APOE ε4 allele), demographic characteristics (e.g. ethnicity, age), health behaviors (e.g. smoking), and physical health and performance variables (e.g. comorbidities) are associated with dementia risk. Additionally, research suggests that psychological factors, such as depressive symptoms predict dementia onset, although depression may be an early manifestation of dementia, or share a common etiology rather than being an independent risk factor (Panza et al., 2010). Activities of Daily Living (ADL) disability has also been linked to dementia (Barberger-Gateau et al., 1999; Fitz and Teri, 1994), however ADL disability is, itself, an outcome based on complex interactions between cognitive, psychological, physical, and environmental factors. This study explores the relationship between ADL disability and incident dementia risk. We will review the components of ADL disability and observe the role of baseline ADL in dementia risk after controlling for known risk factors including baseline global cognitive status and depressive symptoms.
Sources of ADL Disability
Biopsychosocial models of the disablement process (Verbrugge and Jette, 1994) suggest that disability occurs when a person’s capabilities do not meet the demands of the physical and/or social environment. While disability can occur at any age and be caused by a number of factors, when applied to late life the models describe how illness leads to impairments in body systems and eventually how limitations in these systems interact with social and psychological factors to lead to loss of independence. In gerontological research, disability is typically assessed via ability to perform ADL. Basic or Personal Activities of Daily Living (BADL or PADL; Katz et al., 1963) include self-care functions (eating, bathing, dressing, toileting), while Instrumental Activities of Daily Living (IADL; Lawton and Brody, 1969) involve more complex tasks required for independent living (using transportation, shopping, preparing meals, laundry).
As indicated in Figure 1, ADL disability is an outcome based on physical and/or cognitive constraints (Leveille et al., 2004)as well as environmental barriers and/or psychological risk or protective factors (Verbrugge and Jette, 1994). For example, if people are unable to prepare their own meals independently (an IADL), it may be because of severe arthritis limiting hand movement (a physical impairment), or because of cognitive deficits restricting their ability to perform tasks in sequence. Research supports that ADL disability is consistently linked with the ability to perform basic physical tasks (Fauth et al., 2007; 2008; Gill et al., 1995; Hairi et al., 2010) as well as global cognitive abilities (multiple cognitive abilities included in one assessment) and specific cognitive abilities (Fauth et al., 2008; Reed et al., 1989). Environmental, psychological and motivational characteristics may play a lesser, but measureable role in ADL disability. For example, people with functional limitations may become unable to prepare their meal in a home that requires lengthy trips up a staircase to a kitchen or has a stove that is difficult to turn on (environmental barriers). Characteristics of one’s home environment (e.g. safety; Cho et al., 1998) and neighborhood (e.g. negative street characteristics; Beard et al., 2009; substandard housing; Clark and George, 2005) predict disability outcomes for older individuals. Finally, individuals may be more or less able to prepare meals based on their motivation to ignore pain, or complete the task (other psychological factors). Psychological factors such as motivation play a clear role in determining people’s willingness to complete ADL tasks that are challenging (Resnick, 1999). Depressive symptoms consistently predict ADL disability both cross-sectionally (Hairi et al., 2010)and longitudinally (Li and Yeates, 2009; Schillerstrom et al., 2008), with evidence that changes over time in both depressive symptoms and ADL disability are closely intertwined processes (Fauth et al., 2012; Taylor and Lynch, 2004) and somewhat reciprocal in relationship (Ormel et al., 2002).
Figure 1.

ADL Disability predicts Dementia Risk
The Current Study
Currently, associations between ADL disability and dementia are typically identified by observing ADL disability as a diagnostic tool (e.g. one criterion in a clinical dementia diagnosis), or as an indicator of decline over the course of dementia (Fitz and Teri, 1994; Peres et al., 2008). That is, ADL disability is associated with dementia because it is assessed as an outcome of the dementia process. Specifically, individuals with dementia or preclinical dementia first experience disability in the more complex IADL (Barberger-Gateau et al., 1999) although may experience PADL disability in later stages (Fields et al., 2010).
This study does not use ADL to diagnose dementia or to examine how dementia impacts ADL decline; rather we assess the extent to which ADL disability in older adults without dementia predicts subsequent incident dementia. Restated, ADL disability is utilized here as a risk factor for the onset of future dementia (i.e. the outcome of analyses is “yes they developed dementia”, or “no they did not develop dementia”), not as a way to track dementia progression or rate of functional change over time. We would, of course, expect that a relationship exists between ADL disability and risk for dementia onset because preclinical cognitive impairment can be a common cause of both ADL disability and future dementia diagnosis. Unique to this study, however, is that we control for baseline global cognitive function (amalgam of multiple cognitive abilities) and other factors. By doing so, we test whether global cognitive function is the “common cause” for both ADL disability and subsequent dementia onset, or if non-cognitive aspects of ADL (e.g. physical impairment, emotional and environmental resources and barriers) or cognitive factors not captured in our global cognitive assessment (e.g. executive function; Woodford & George, 2007) remain key indicators in determining dementia risk. Because emotional well-being and depressive symptoms are linked to cognitive impairment and dementia (Wilson et al., 2002),we also control for depressive symptoms.
We hypothesize that ADL disability will predict dementia risk, even after controlling for global cognitive status and depressive symptoms. Specifically, we propose that ADL function will predict future dementia onset net of global cognitive status and depressive symptoms because of the physical frailty and executive function components of ADL disability. Research supports the idea that incident dementia is predicted by physical frailty (Buchman et al., 2008a) and specific physical abilities such as poorer grip strength and gait (Buchman et al., 2008b; Rosano et al., 2005; Wang et al., 2006), and physical frailty is a key contributor to ADL. Likewise, executive function is the ability to plan and execute goals, including processes of reasoning and judgment (Lezak, 1995), and it has been found to be more sensitive than global cognitive tests at predicting cerebral events such as postoperative delirium (Greene et al., 2009) as well as ADL impairment (Johnson et al., 2007), but is not assessed in our global measure of cognitive status.
METHODS
Study Overview and Participants
Data come from the Cache County Memory Study (CCMS), a large population-based study of older individuals in northern Utah, approved by institutional review boards at Utah State University, Duke University, and Johns Hopkins University. Informed consent was acquired for all participants at each visit, and participants were provided $20.00 for the initial screening, and $50.00 for each additional in-depth visit. In 1995 residents of Cache County aged 65+ were contacted (5,756 individuals). Ninety percent of these agreed to participate (N=5,092). Individuals provided information on a large battery of questions assessing health and health behavior, psychological and social resources, nutrition, and provided samples for genetic testing. Interviews were conducted in four triennial waves. In addition, the study utilized a comprehensive multi-stage protocol to diagnose dementia (see Breitner et al., 1999 for a detailed description). In short, an in depth neuropsychological assessment was performed in the home by a nurse and research technician, with results reviewed by a geriatric psychiatrist and neuropsychologist. Participants were diagnosed with dementia using criteria defined by the Diagnostic and Statistical Manual of Mental Disorders, Third Edition-Revised (DSM-IIIR; American Psychiatric Association, 1987). The DSM-IIIR does not include ADL limitations as part of the diagnosis for dementia, in contrast to other diagnostic criteria such as ICD-10 (World Health Organization, 1992) and CAMDEX (Roth et al., 1986) where ADL impairment is a required criterion (Erkinjuntti et al., 1997). In addition, we used the DSM-IIIR criteria except that we did not require a demonstrable deficit in both short-term and long-term memory, but allowed one or the other (Breitner et al., 1999) which is more consistent with subsequent revisions of the DSM (DSM-IV; DSM-IV-TR). Thus, our criteria for diagnosis did not change over all waves of CCMS, and our modification to the DSM-IIIR specification made our criteria alike to that of DSM-IV and DSM-IV-TR. Individuals with working diagnosis of dementia also completed a psychiatrist’s examination, imaging and lab studies. A multidisciplinary consensus panel reviewed all available data and assigned final consensus dementia diagnoses, with additional clinical follow-up at 18 months.
Of the initial 5,092 CCMS participants, 583 developed dementia. Individuals with prevalent dementia at the initial visit of the study (N=359), and those with unknown dementia status (N=188) were excluded from the current analyses, as were those with missing data on independent variables or covariates, yielding a baseline sample of N = 4404 (571 incident dementia). Finally, because the current analyses required longitudinal data, 857 individuals with no follow-up data were excluded. The final sample for these analyses was N = 3547 (571 incident dementia). Within our final sample, we had 58.6% attrition (2078 individuals were missing follow-up at waves 3 or 4), with participant death as the main reason for dropout (48.1%). Those that dropped out of the study were compared to those that completed all 4 visits. The attrition group did not differ in terms of APOE status, gender, ethnicity, or depressive symptoms, but were more likely to be older (t(3545)=−23.57, p< .001), have fewer years of education (t(3545)=7.23, p< .001), have lower scores of cognitive ability (t(3545)=16.67, p< .001), and were less likely to be married (χ2 = 112.72, p<0.01, d.f.= 4).
Measures
Activities of Daily Living Disability
Disability was assessed via self-reported ability to independently perform ADL. Seven PADL included eating, bathing/grooming, walking long distances, mobility without cane or walker, getting up/down, toileting, and needing reminders for toileting. Eleven IADL included traveling beyond walking distance, meal preparation, laundry, light housework, heavier chores, using the telephone, shopping, grocery shopping, shopping for other things, taking medications, and managing finances. If an individual needed assistance on 1+ PADLs or 2+ IADLs, he or she was considered to have ADL disability. In the past, disability was defined as difficulty in 1+ PADL tasks (Guralnik et al., 2002; Seeman et al., 1996; Sun et al., 2007) or 1+ IADL or PADL tasks (Ishizaki et al., 2002; Konno et al., 2004). Iwashina and Christie (2007) defined disability as 2 + PADLs or 2 + IADLs. For the current study we wished to utilize all ADL data (both PADL and IADL), but recognized that IADL tasks are more complex in nature, and individuals typically become IADL impaired before they become PADL impaired (Judge et al., 1996). Thus someone who is unable to perform 1 IADL task may be “less disabled” than someone who is unable to perform 1 PADL task. This guided our decision to use the criteria for ADL disability to needing assistance in 1 + PADL or 2 + IADLs. For parsimony the ADL variable will include both PADL and IADL impairment, but models will also be run separately using just PADL impairment, and just IADL impairment to compare results.
Covariates
Age, APOE status (ε4 carriers vs. ε4 non-carriers; Corder et al., 1993; Schneider et al., 2006) gender, baseline cognitive ability, and baseline depressive symptoms were included in the models. Global cognitive ability was assessed via the 3MS-R (Tschanz et al., 2002), a modified version of the 3MS (Teng and Chui, 1987), which itself is derived from the Mini-Mental State exam (MMSE; Folstein et al., 1975). The 3MS and 3MS-R were designed to cover a broader range of global cognitive abilities than the MMSE. Scores range from 1–100. The current 3MS-R score used in the analyses is adjusted for education level.
Depressive symptoms were assessed via the modified Diagnostic Interview Schedule (DIS; Stephens et al., 2000). The modified DIS includes 3 ‘gateway questions’ assessing feelings of sadness, loss of interest or irritability. If an individual endorsed at least one gateway symptom, he or she completed the remainder of the DIS. Results from the full DIS were used to determine if an individual met the criteria for major depression according to the DSM-IV (American Psychiatric Association, 2000). In the current analyses, any individual who endorsed the presence of 1+ gateway symptoms was considered to have at least minor depressive symptoms. Our dichotomous variable distinguishes those without minor symptoms (none of the gateway items endorsed) vs. those with any level of minor or major depressive symptoms. We also ran all analyses including a trichotomous depressive symptoms variable of 0 (no symptoms), 1 (minor symptoms: endorsing one or more gateway questions but not meeting DSM-IV criteria for depression based on DIS results), and 2 (major depression as defined by DSM-IV criteria). Because the results did not differ when we used the latter specification, the dichotomous, more parsimonious, version is reported herein.
Statistical Analyses
The outcome of interest was time (in years) from initial visit to dementia onset. Those who did not develop dementia over the course of the study were right-censored as of the last measurement occasion prior to death, or to end of follow-up. Separate Kaplan Meier (KM) plots and Mantel-Cox log rank tests of equality were used to assess associations between 1) ADL disability and dementia, 2) 3MS-R quartiles and dementia, and 3) depressive symptoms and dementia. For the final model, Cox regression analysis tested whether ADL disability predicted dementia in the presence of covariates. Post hoc analyses were run separately using just PADL disability and just IADL disability to determine if these models differed from those using ADL disability (combining PADL and IADL disability together).
RESULTS
Demographic analyses of the sample revealed that 69.6% of the sample was married at baseline, 26.1% were widowed, and the remaining 4.3% were separated, divorced, or never married. The sample was mostly White (99.5%), and occupation groups were reported as 33.9% of the sample in professional/managerial positions, 22.2% in clerical/sales, 15.1% in mechanical/miscellaneous, 10.5% agricultural, 9.8% service, and 8.5% never employed. Table 1 provides the demographic characteristics for the entire CCMS sample, and separately for those reporting ADL disability and no disability at baseline. The group that reported disability (18.1% of the sample) was significantly more likely to be female (χ2(1) = 54.3, p < 0.001), less likely to carry APOE allele 4 (χ2(1) = 8.3, p = 0.004), more likely to report depressive symptoms (χ2(1) = 43.5, p < 0.001), and more likely to develop incident dementia (χ2(1) = 50.1, p < 0.001). T-test comparisons revealed statistically significant differences between the ADL disability and non-disability groups such that, on average, the ADL disability group was older (t(3545) = −22.7, p<0.001), had less education (t(3545) = 8.0, p<0.001), lower 3MS-R score (t(3545) = 17.4, p<0.001), and fewer years to dementia onset (t(569) = 6.3, p<0.001).
Table 1.
Basic Descriptive Characteristics of the Sample
| ADL Disabled at Initial Visit | Total | |||||
|---|---|---|---|---|---|---|
| No | Yes | |||||
| N (%) | 2905 (81.9%) | 642 (18.1%) | 3547 (100%) | |||
|
| ||||||
| N | % | N | % | N | % | |
|
| ||||||
| Female Gender | 1598 | 55.0 | 455 | 70.9 | 2053 | 57.9 |
| APOE allele 4 is Present | 853 | 32.8 | 173 | 26.9 | 1126 | 31.7 |
| Depressive Symptoms* | 118 | 4.1 | 67 | 10.5 | 185 | 5.2 |
| Developed Incident Dementia | 408 | 14.0 | 163 | 25.4 | 571 | 16.1 |
|
| ||||||
| Mean | SD | Mean | SD | Mean | SD | |
|
| ||||||
| Age (years)* | 73.79 | 5.9 | 80.0 | 7.8 | 74.9 | 6.7 |
| Education (years) | 13.54 | 2.9 | 12.55 | 2.8 | 13.36 | 2.9 |
| Cognitive Ability (3MS-R)* † | 92.31 | 5.4 | 87.67 | 8.8 | 91.47 | 6.4 |
| Years-to-Right Censoring | 7.78 | 3.7 | 4.96 | 3.6 | 7.32 | 3.8 |
| Years-to-Dementia | 6.01 | 3.3 | 4.17 | 2.9 | 5.52 | 3.3 |
Notes:
measurement at baseline;
adjusted for education; For all categorical measures, Chi-square differences between the ADL disability and no disability groups indicates statistically significant (p <0.010). For all continuous measures, t-tests between the ADL disability and no disability groups scores indicates statistically significant (p <0.001).
A KM plot showed (without the inclusion of covariates) that the relationship between the survival functions of ADL disability vs. no disability groups was fairly constant over time, meeting the proportional hazards assumption (see Figure 2). The associated log rank test of equality was significant (p<0.001), indicating that those with ADL disability were at higher risk for dementia, compared to those without ADL disability. Similarly, the KM plot for the 3MS-R score quartiles displayed relationships between the survival functions to be fairly constant over time, and the log rank was also significant (p<0.001), indicating that those with lower baseline global cognitive ability were also at higher risk for dementia. However, the KM plot for depressive symptoms (symptoms present or not) did not display clear distinction between groups in terms of dementia risk (log rank n.s.; p = 0.7).
Figure 2.
Survival Function for Prototypical Participant (75 year old male, not a APOE 4 carrier, 13 years of education & average 3MS-R score of 91.47): Plotted with and without ADL disability at baseline.
These three variables were all carried forward into a Cox regression analysis, along with known dementia risk factors as covariates: age, gender, and APOE status (education was adjusted for in the 3MS-R score, and was therefore not included as a separate covariate). Because age is a known predictor of dementia risk and we wished to control for it, all Cox regression models were stratified by age quartile, in addition to including age as a covariate in the model. The advantage to this approach is that birth cohort effects are minimized because parameters are estimated separately within birth cohort quartiles, then aggregated into final results (Cleves et al., 2008). Therefore results for age should be interpreted as the effect of an additional year of age on dementia risk within a given quartile.
Table 2 displays the multivariate Cox regression results. Having the APOE ε4 allele yielded an 80% higher risk of dementia compared to those without the allele, and every point reduction in 3MS-R score yielded an 8% increase of developing dementia. After controlling for gender, age, APOE, education adjusted 3MS-R, and the presence of depressive symptoms, ADL carried an 83% higher risk of developing incident, compared to those without baseline ADL disability.
Table 2.
Multivariate Cox Proportional Hazards Regression Model
| Variables in the Equation | ||||||||
|---|---|---|---|---|---|---|---|---|
| B | SE | Wald | df | Sig. | Exp (B) | 95.0% CI for Exp(B) | ||
| Lower | Upper | |||||||
| Gender (Female) | 0.06 | 0.09 | 0.51 | 1 | 0.48 | 1.07 | 0.90 | 1.27 |
| Age | 0.02 | 0.02 | 1.67 | 1 | 0.20 | 1.02 | 0.99 | 1.05 |
| APOE allele 4 | 0.59 | 0.09 | 46.87 | 1 | 0.00 | 1.80 | 1.52 | 2.14 |
| 3MS-R* | −0.08 | 0.01 | 178.82 | 1 | 0.00 | 0.92 | 0.91 | 0.93 |
| Depressive Symptoms | −0.26 | 0.20 | 1.71 | 1 | 0.19 | 0.77 | 0.53 | 1.14 |
| ADL Disability | 0.61 | 0.11 | 30.62 | 1 | 0.00 | 1.83 | 1.48 | 2.27 |
Note: for all variables, measurements occurred at baseline.
Education Adjusted 3MS-R score
Post hoc analyses explored whether IADL or PADL had differential associations with dementia risk. The presence of 2+ IADL occurred for 14.2% of the sample and 1+ PADL occurred for 11.4% of the sample at baseline, with high levels of co-occurrence (χ2(1)=989.52, p<.001). Cox regression models (including above covariates) yielded highly similar outcomes to each other and to models using the combined ADL variable; baseline PADL disability yielded a 76% higher risk of dementia than those without PADL disability, and baseline IADL disability yielded a 75% higher risk of dementia than those without IADL disability. Due to high levels of agreement across all models, only results for the combined ADL models are presented in the current study.
CONCLUSION
Late-life ADL disability is influenced by physical and cognitive abilities and to a lesser extent by psychological and environmental factors. In addition, ADL is associated with dementia-related outcomes. One would expect that if an individual’s ADL disability is rooted in his or her cognitive deficit, the link between ADL and subsequent dementia would be explained by the common underlying cause of cognitive impairment. The current study, however, examined whether or not ADL disability status predicted future dementia after controlling for baseline global cognitive status (and other known risk factors, including baseline depressive symptoms). In our study, ADL disability remained a significant predictor of dementia risk, even after controlling for baseline cognitive status, suggesting that 1) non-cognitive influences on the ADL/dementia association may be important; and/or 2) cognitive influences not captured in the 3MS-R global cognitive assessment may influence the ADL/dementia association.
Past research also links emotional factors with both ADL disability and dementia risk, for example increased depressive symptoms are associated with poorer ADL function (Hairi et al., 2010; Li and Yeates, 2009; Schillerstrom et al., 2008) and increased risk for dementia (Wilson et al., 2002). In our sample, chi-square tests revealed that the ADL disability group was more likely to report the presence of depressive symptoms, but KM plots and Cox regression models did not find baseline depressive symptoms to be related to dementia risk. Nonetheless, we controlled for the presence of depressive symptoms in these analyses, and ADL disability remained a strong predictor of dementia. Our results indicate depressive symptoms are not likely to be the driving factor behind the ADL/dementia risk association, suggesting that physical impairment, environmental resources/barriers, or cognitive tasks not included in our global cognitive assessment are likely to be the more important factors in ADL impairment that predict subsequent dementia risk. Our inability to identify depressive symptoms as predictive of future dementia may be related to measurement issues, or may indicate that earlier depressive symptoms do not, in fact, predict subsequent dementia. The DIS and its three “gateway questions” (see methods section for details) may not have captured the same kind of variability found in measures of depressive symptoms that mark the presence or frequency of a long list of depressive symptoms (e.g. the Center for Epidemiologic Studies Depression Scale, Radloff, 1977; or Geriatric Depression Scale, Yesavage et al., 1982). Research has found differences in terms of sensitivity across these three measures of depression and depressive symptoms (Blank et al., 2004). In addition, only 5% of our sample reported depressive symptoms at baseline, thus statistical power to detect associations may be low. Alternatively, the lack of statistically significant associations in the current analyses may be explained by the fact that our study measures associations between baseline depressive symptoms and future dementia onset. Perhaps associations between depressive symptoms and dementia are stronger when they are assessed concurrently.
There are several possible mechanisms supported by research explaining how physical features of ADL impairment are related to dementia risk after controlling for global cognitive status and depressive symptoms. First, underlying preclinical dementia factors could be driving baseline physical impairment. In other words, the same pathology that eventually causes dementia may also cause reductions in physical abilities associated with daily functioning. In older individuals without Parkinson’s disease, Schneider and colleagues (2006) found that neurofibrillary tangles in the substantia nigra were related to gait ability, an example of how preclinical cognitive impairment may share etiology in brain pathology with physical performance tasks. An alternative explanation is that there is specific pathology impacting ADL disability that simply exacerbates dementia progression. For example, vascular problems may lead to poorer health and physical function (Ettinger et al., 1994) but also place a person at greater risk for Alzheimer’s disease (Kivipelto et al., 2001). We also acknowledge that mechanisms for how ADL impairment impacts dementia risk may differ depending on the source of the ADL impairment. For example vascular problems may be a driving factor in subsequent dementia if a stroke or diabetes has caused the initial ADL disability, whereas other processes factors may be operating if the initial ADL impairment was caused by a fall, general frailty, or other pathology. ADL impairment is an outcome that can result from multiple pathways, and the same can be said for dementia. Thus while our study demonstrates the potential for ADL to serve as a predictive measure for dementia onset, we cannot presume that all ADL impairment, all dementia, and the associations between the two will fall along the same pathway or mechanism.
Likewise, as suggested above, cognitive abilities not captured in the global 3MS-R, such as executive function, may contribute to both baseline ADL impairment and subsequent dementia risk. Even by controlling for global cognitive impairment, we have not ruled out the possibility that some kind of cognitive impairment is still an underlying feature of both ADL impairment and future dementia onset. Executive function, in particular, should be further examined as a “common cause” risk factor.
Strengths, Limitations and Future Directions
The unique characteristics of the CCMS sample and design allow us to measure ADL disability and other covariates prior to dementia onset, and also to study dementia outcomes without relying on clinical settings for recruiting participants, however the sample has low levels of ethnic minority participants, and findings may not be generalizable to ethnic minority populations. Future studies should utilize epidemiological samples from diverse populations to observe whether these same relationships emerge, and whether the different components of ADL disability carry comparable levels of risk for dementia. We also acknowledge that at baseline, the mean score of the 3MS-R in our sample was 91 out of 100, reflecting a possible ceiling effect. While this measure likely discriminated among individuals with cognitive impairment and those without, future studies should include global cognitive measures that are designed to be sensitive at discriminating cognitive ability among non-impaired individuals with higher levels of cognitive function. Also, while this is a longitudinal study, only baseline predictors were used. Future research should observe how changes in ADL, cognitive ability, and depression work together to predict dementia. Finally, although it was only part of our descriptive analyses of the sample and not central to our research question, future research should more closely examine our finding that carriers of the APOE4 allele were more likely to be in the non-disabled group at baseline. Prior research has revealed mixed findings, sometimes suggesting that APOE4 is a risk factor for functional disability, even after controlling for cognitive status (Albert et al. 1995), but other times finding no association between APOE and ADL function (Melzer et al., 2005; Tzuo et al., 2009). The fact that our study found differences across ADL impaired and ADL non-impaired groups, but in the opposite direction to that of Albert and colleagues needs further examination.
We have presented general, but powerful results to suggest that ADL disability is a strong predictor of future dementia, even after controlling for global cognition and depression. While there were many people with baseline ADL impairment that did not develop dementia over the course of the study, we propose that, net of covariates included in the model, identifying that there was an 83% higher risk for developing dementia among those with baseline ADL impairment is not trivial. We suggest that future studies expand upon these results by further teasing apart the role of specific cognitive tasks (e.g. executive function) and the role of underlying physical impairment and pathology. Currently, researchers consider mild cognitive impairment as a “warning sign” or risk factor for future dementia. The current study suggests that we should also consider ADL impairment not only as a diagnostic tool for dementia, or a way to determine dementia stages post-diagnosis, but as part of the risk profile for future dementia, even in individuals who are not impaired on global cognitive tests. While ADL disability alone does not indicate that future dementia will occur, ADL function may serve additional utility when added to a larger battery of variables used to determine dementia risk.
Acknowledgments
Funding Sources: R01AG-031272, R01AG-11380, and R01AG21136.
We appreciate support from National Institute on Aging grants R01AG-031272, R01AG-11380, and R01AG21136. We wish to thank the neurogenetics laboratory of the Bryan Alzheimer’s Disease Research Center at Duke University for the APOE genotyping, and to Cara Brewer, BA, Tony Calvert, BSC, Michelle McCart, BA, Tiffany Newman, BA, Roxane Pfister, M.S., Russell Ray, MS, Nancy Sassano, PhD, Linda Sanders, MPH, Leslie Toone, MS, and Joslin Werstak, BA for expert technical assistance. Other Cache County Study Investigators include: James Anthony, PhD, Erin Bigler, PhD, Ron Brookmeyer, PhD, James Burke, MD, PhD, Eric Christopher, MD, Jane Gagliardi, MD, Robert Green, MD, Michael Helms, MS, Christine Hulette, MD, Ara Khachaturian, PhD, Liz Klein, MPH, Carol Leslie, MS, Constantine Lyketsos, MD, MHS, Lawrence Mayer, PhD, John Morris, MD, Ron Munger, PhD, MPH, Chiadi Onyike, MD, MHS, Ron Petersen, MD, Kathy Piercy, PhD, Carl Pieper, DrPH, Brenda Plassman, PhD, Peter Rabins, MD, Pritham Raj, MD, Ingmar Skoog, MD, Ph.D., David Steffens, MD, MHS, Martin Steinberg, MD, Marty Toohill, PhD, Jeannette Townsend, MD, Lauren Warren, PhD, Heidi Wengreen, PhD, Michael Williams, MD, and Bonita Wyse, PhD. Neuropsychological testing and clinical assessment procedures were developed by Drs. Kathleen Welsh-Bohmer and John Breitner. Dr. JoAnn Tschanz provided training and oversight of all field staff and reviewed all individual neuropsychological test results to render professional diagnoses. The board-certified or board-eligible geriatric psychiatrists or neurologists who examined the study members included Drs Steinberg, Breitner, Steffens, Lyketsos, Gagliardi, Raj, Christopher, and Green. Dr. Townsend performed autopsies. Ms. Leslie coordinated the autopsy enrollment program. Diagnosticians at the expert consensus conferences included Drs Breitner, Burke, Lyketsos, Plassman, Steffens, Steinberg, Toohill, Tschanz, and Welsh-Bohmer.
References
- Albert SM, Gurland B, Maestre G, et al. APOE genotype influences functional status among elderly without dementia. Am J Med Genet. 1995;60:583–587. doi: 10.1002/ajmg.1320600621. [DOI] [PubMed] [Google Scholar]
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3. Washington, DC: Author; 1987. rev. [Google Scholar]
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4. Washington, DC: Author; 2000. text revision. [Google Scholar]
- Barberger-Gateau P, Fabrigoule C, Rouch I, et al. Neuropsychological correlates of self-reported performance in instrumental activities of daily living and prediction of dementia. J Gerontol B Psychol Sci Soc Sci. 1999;54B:P293–P303. doi: 10.1093/geronb/54B.5.P293. [DOI] [PubMed] [Google Scholar]
- Beard JR, Blaney S, Cerda M, et al. Neighborhood characteristics and disability in older adults. J Gerontol B Psychol Sci Soc Sci. 2009;64B:252–257. doi: 10.1093/geronb/gbn018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Blank K, Gruman C, Robison JT. Case-finding for depression in elderly people: balancing ease of administration with validity in varied treatment settings. J Gerontol A Biol Sci Med Sci. 2004;59:M378–M384. doi: 10.1093/gerona/59.4.M378. [DOI] [PubMed] [Google Scholar]
- Breitner JC, Wyse BW, Anthony JC, et al. APOE4 count predicts age when prevalence of AD increases, then declines, the Cache County Study. Neurol. 1999;5:321–331. doi: 10.1212/wnl.53.2.321. [DOI] [PubMed] [Google Scholar]
- Buchman AS, Schneider JA, Leurgans S, et al. Physical frailty in older persons is associated with Alzheimer disease pathology. Neurol. 2008a;71:499–504. doi: 10.1212/01.wnl.0000324864.81179.6a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Buchman AS, Wilson RS, Boyle PA, et al. Grip strength and the risk of incident Alzheimer’s disease. Neuroepidemiology. 2008b;29:66–73. doi: 10.1159/000109498. [DOI] [PubMed] [Google Scholar]
- Chen JH, Lin KP, Chen YC. Risk factors for dementia. J Formos Med Assoc. 2009;108:754–764. doi: 10.1016/S0929-6646(09)60402-2. [DOI] [PubMed] [Google Scholar]
- Cho CY, Alessi CA, Cho M, et al. The association between chronic illness and functional change among participants in a comprehensive geriatric assessment program. J Am Geriatr Soc. 1998;46:677–682. doi: 10.1111/j.1532-5415.1998.tb03800.x. [DOI] [PubMed] [Google Scholar]
- Clarke P, George LK. The role of the built environment in the disablement process. Am J Public Health. 2005;95:1933–1939. doi: 10.2105/AJPH.2004.054494. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cleves M, Gould WW, Gutierrez RG, et al. An introduction to survival analysis using Stata. 2. Chicago, IL: Stata Press; 2008. [Google Scholar]
- Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science. 1993;261:921–923. doi: 10.1126/science.8346443. [DOI] [PubMed] [Google Scholar]
- Cress ME, Schechtman KB, Mulrow CD, et al. Relationship between physical performance and self-perceived physical function. J Am Geriatr Soc. 1995;43:93–101. doi: 10.1111/j.1532-5415.1995.tb06372.x. [DOI] [PubMed] [Google Scholar]
- Daviglus ML, Bell CC, Berrettini W, et al. NIH Conferences: National Institutes of Health state-of-the-science conference statement: preventing Alzheimer disease and cognitive decline. Ann Intern Med. 2010;153:176–181. doi: 10.7326/0003-4819-153-3-201008030-00260. [DOI] [PubMed] [Google Scholar]
- Erkinjuntti T, Østbye T, Steenhuis R, et al. The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med. 1997;337:1667–1674. doi: 10.1056/NEJM199712043372306. [DOI] [PubMed] [Google Scholar]
- Ettinger WH, Jr, Fried LP, Harris T, et al. Self-reported causes of physical disability in older people: the Cardiovascular Health Study. J Am Geriatr Soc. 1994;42:1035–1044. doi: 10.1111/j.1532-5415.1994.tb06206.x. [DOI] [PubMed] [Google Scholar]
- Fauth EB, Gerstorf D, Ram N, et al. Changes in depressive symptoms in the context of disablement processes: Role of demographic characteristics, cognitive function, health, and social support. J Gerontol B Psychol Sci Soc Sci. 2012;67B:167–177. doi: 10.1093/geronb/gbr078. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fauth EB, Zarit SH, Malmberg B, et al. Physical, cognitive, and psychosocial variables from the Disablement Process Model predict patterns of change in disability for the oldest-old. Gerontologist. 2007;47:613–624. doi: 10.1093/geront/47.5.613. [DOI] [PubMed] [Google Scholar]
- Fauth EB, Zarit SH, Malmberg B. Mediating relationships within the disablement process model: A cross-sectional study of the oldest-old. European Journal of Aging. 2008;5:161–179. doi: 10.1007/s10433-008-0092-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fields JA, Machulda M, Aakre J, et al. Utility of the DRS for predicting problems in day-to-day functioning. Clin Neuropsychol. 2010;24:1167–1180. doi: 10.1080/13854046.2010.514865. [DOI] [PubMed] [Google Scholar]
- Fitz AG, Teri L. Depression, cognition, and functional ability in patients with Alzheimer’s disease. J Am Geriatr Soc. 1994;42:186–191. doi: 10.1111/j.1532-5415.1994.tb04950.x. [DOI] [PubMed] [Google Scholar]
- Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
- Gill TM, Williams CS, Tinetti ME. Assessing risk for the onset of functional dependence among older adults: The role of physical performance. J Am Geriatr Soc. 1995;43:603–609. doi: 10.1111/j.1532-5415.1995.tb07192.x. [DOI] [PubMed] [Google Scholar]
- Greene NH, Attix DK, Weldon BC, et al. Measures of executive function and depression identify patients at risk for postoperative delirium. Anesthesiology. 2009;110:788–795. doi: 10.1097/ALN.0b013e31819b5ba6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Guralnik JM, Alecxih L, Branch LG, et al. Medical and long-term care cost when older persons become more dependent. Am J Public Health. 2002;92:1244–1245. doi: 10.2105/AJPH.92.8.1244. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hairi NN, Bulgiba A, Cumming RG, et al. Prevalence and correlates of physical disability and functional limitation among community dwelling older people in rural Malaysia, a middle income country. BMC Public Health. 2010;10:492. doi: 10.1186/1471-2458-10-492. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ishizaki T, Kai I, Kobayashi Y, et al. Functional transitions and active life expectancy for older Japanese living in a community. Arch Gerontol Geriatr. 2002;35:107–120. doi: 10.1016/S0167-4943(02)00002-X. [DOI] [PubMed] [Google Scholar]
- Iwashyna TJ, Christie JD. Low use of durable medical equipment by chronically disabled elderly. J Pain Symptom Manage. 2007;33:324–330. doi: 10.1016/S0885-3924(07)00349-1. [DOI] [PubMed] [Google Scholar]
- Johnson JK, Lui L, Yaffe K. Executive function, more than global cognition, predicts functional decline and mortality in elderly women. J Gerontol A Biol Sci Med Sci J Gerontol A Biol Sci Med Sci. 2007;62:1134–1141. doi: 10.1093/gerona/62.10.1134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Judge JO, Schechtman K, Cress E. The relationship between physical performance measures and independence in instrumental activities of daily living. The FICSIT Group. Frailty and Injury: Cooperative Studies of Intervention Trials. J Am Geriatr Soc. 1996;44:1332–41. doi: 10.1111/j.1532-5415.1996.tb01404.x. [DOI] [PubMed] [Google Scholar]
- Katz S, Ford AB, Moskowitz RW, et al. Studies of illness and the aged. The index of ADL: A standardized measure of biological and psychosocial function. JAMA. 1963;185:914–923. doi: 10.1001/jama.1963.03060120024016. [DOI] [PubMed] [Google Scholar]
- Kivipelto M, Helkala E, Laakso MP, et al. Midlife vascular risk factors and Alzheimer’s disease in later life: longitudinal, population based study. BMJ. 2001;322:1447–1451. doi: 10.1136/bmj.322.7300.1447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Konno K, Katsumata Y, Arai A, et al. Functional status and active life expectancy among senior citizens in a small town in Japan. Arch Gerontol Geriatr. 2004;38:153–166. doi: 10.1016/j.archger.2003.09.002. [DOI] [PubMed] [Google Scholar]
- Lawton MP, Brody EM. Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179–186. doi: 10.1093/geront/9.3_Part_1.179. [DOI] [PubMed] [Google Scholar]
- Leveille SG, Fried LP, McMullen W, et al. Advancing the taxonomy of disability in older adults. J Gerontol A Biol Sci Med Sci. 2004;59:M86–M93. doi: 10.1093/gerona/59.1.M86. [DOI] [PubMed] [Google Scholar]
- Lezak MD. Neuropsychological assessment. Vol. 3. New York: Oxford University Press; 1995. [Google Scholar]
- Li LW, Yeates C. Effects of changes in depressive symptoms and cognitive functioning on physical disability in home care elderly. J Gerontol A Biol Sci Med Sci. 2009;64:230–236. doi: 10.1093/gerona/gln023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McCullagh CD, Craig D, McIlroy SP, et al. Risk factors for dementia. APT. 2001;7:24–31. doi: 10.1192/apt.7.1.24. [DOI] [Google Scholar]
- Melzer D, Dik MG, van Kamp GJ, et al. The apolipoprotein E e4 polymorphism is strongly associated with poor mobility performance test results but not self-reported limitation in older people. J Gerontol A Biol Sci Med Sci. 2005;60A:M1319–M1323. doi: 10.1093/gerona/60.10.1319. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ormel J, Rijsdijk FV, Sullivan M, et al. Temporal and reciprocal relationship between IADL/ADL disability and depressive symptoms in late life. J Gerontol B Psychol Sci Soc Sci. 2002;57:P338–P347. doi: 10.1093/geronb/57.4.P338. [DOI] [PubMed] [Google Scholar]
- Panza F, Frisardi V, Capurso C, et al. Late-life depression, mild cognitive impairment, and dementia: Possible continuum? Am J Geriatr Psychiatry. 2010;18:98–116. doi: 10.1097/JGP.0b013e3181b0fa13. [DOI] [PubMed] [Google Scholar]
- Peres K, Helmer C, Amieva H, et al. Natural history of decline in instrumental activities of daily living performance over the 10 years preceding the clinical diagnosis of dementia: A prospective population-based study. J Am Geriatr Soc. 2008;56:37–44. doi: 10.1111/j.1532-5415.2007.01499.x. [DOI] [PubMed] [Google Scholar]
- Radloff LS. The CES-D scale: A self report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401. [Google Scholar]
- Reed BR, Jagust WJ, Seab JP. Mental status as a predictor of daily function in progressive dementia. Gerontologist. 1989;29:804–807. doi: 10.1093/geront/29.6.804. [DOI] [PubMed] [Google Scholar]
- Resnick B. Motivation to perform activities of daily living in the institutionalized older adult: Can a leopard change its spots? J Adv Nurs. 1999;29:792–799. doi: 10.1046/j.1365-2648.1999.00954.x. [DOI] [PubMed] [Google Scholar]
- Rosano C, Simonsick EM, Harris TB, et al. Association between physical and cognitive function in healthy elderly: The Health, Aging and Body Composition Study. Neuroepidemiology. 2005;24:8–14. doi: 10.1159/000081043. [DOI] [PubMed] [Google Scholar]
- Roth M, Tym E, Mountjoy CQ, et al. CAMDEX: a standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry. 1986;149:698–709. doi: 10.1192/bjp.149.6.698. [DOI] [PubMed] [Google Scholar]
- Schillerstrom JE, Royall DR, Palmer RF. Depression, disability and intermediate pathways: A review of longitudinal studies in elders. J Geriatr Psychiatry Neurol. 2008;21:183–197. doi: 10.1177/0891988708320971. [DOI] [PubMed] [Google Scholar]
- Schneider JA, Li JL, Li Y, et al. Substantia nigra tangles are related to gait impairment in older persons. Ann Neurol. 2006;59:166–173. doi: 10.1002/ana.20723. [DOI] [PubMed] [Google Scholar]
- Seeman TE, Bruce ML, McAvay GJ. Social network characteristics and onset of ADL disability: MacArthur studies of successful aging. J Gerontol B Psychol Sci Soc Sci. 1996;51B:S191–S200. doi: 10.1093/geronb/51B.4.S191. [DOI] [PubMed] [Google Scholar]
- Steffens DC, Skoog I, Norton MC, et al. Prevalence of depression and its treatment in an elderly population. The Cache County, Utah Study. Arch Gen Psychiatry. 2000;57:601–607. doi: 10.1001/archpsyc.57.6.601. [DOI] [PubMed] [Google Scholar]
- Sun W, Watanabe M, Tanimoto Y, et al. Factors associated with good self-rated health of non-disabled elderly living alone in Japan: A cross-sectional study. BMC Public Health. 2007;7:297–299. doi: 10.1186/1471-2458-7-297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Taylor MG, Lynch SM. Trajectories of impairment, social support, and depressive symptoms in later life. J Gerontol B Psychol Sci Soc Sci. 2004;59B:S238–S246. doi: 10.1093/geronb/59.4.S238. [DOI] [PubMed] [Google Scholar]
- Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry. 1987;48:314–318. [PubMed] [Google Scholar]
- Tschanz JT, Welsh-Bohmer KA, Plassman BL. An adaptation of the Modified Mini-Mental Status Exam: Analysis of demographic influences and normative data. The Cache County Study. Cog Behav Neurol. 2002;15:28–38. [PubMed] [Google Scholar]
- Tzuo-Yun L, Wen-Chiung C, Tsuo-Hung L, et al. Apolipoprotein E genotype and risk of developing physical limitations in elderly people. J Am Geriatr Soc. 2009;57:1308–1309. doi: 10.1111/j.1532-5415.2009.02292.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Verbrugge LM, Jette AM. The disablement process. Soc Sci Med. 1994;38:1–14. doi: 10.1016/0277-9536(94)90294-1. [DOI] [PubMed] [Google Scholar]
- Wang L, Larson EB, Bowen JD, et al. Performance-based physical function and future dementia in older people. Arch Int Med. 2006;166:1115–1120. doi: 10.1001/archinte.166.10.1115. [DOI] [PubMed] [Google Scholar]
- Wilson RS, Barnes LL, Mendes de Leon CF, et al. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology. 2002;59:364–370. doi: 10.1212/wnl.59.3.364. [DOI] [PubMed] [Google Scholar]
- Woodford HJ, George J. Cognitive assessment in the elderly: a review of clinical methods. QJM. 2007;100:469–484. doi: 10.1093/qjmed/hcm051. [DOI] [PubMed] [Google Scholar]
- World Health Organization. ‘Mental and behavioural disorders (F00–F99)’, in International statistical classification of diseases and related health problems. 10. ICD-10. New York, NY: Author; 1992. pp. 311–388. Rev. ed. [Google Scholar]
- Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17:37–49. doi: 10.1016/0022-3956(82)90033-4. [DOI] [PubMed] [Google Scholar]

